Jones, Nicholas http://orcid.org/0000-0003-4846-5117
Blagih, Julianna
Zani, Fabio
Rees, April
Hill, David G.
Jenkins, Benjamin J.
Bull, Caroline J. http://orcid.org/0000-0002-2176-5120
Moreira, Diana
Bantan, Azari I. M.
Cronin, James G. http://orcid.org/0000-0002-0590-9462
Avancini, Daniele
Jones, Gareth W. http://orcid.org/0000-0002-0125-4841
Finlay, David K.
Vousden, Karen H. http://orcid.org/0000-0002-7365-1766
Vincent, Emma E. http://orcid.org/0000-0002-8917-7384
Thornton, Catherine A.
Article History
Received: 29 April 2020
Accepted: 14 January 2021
First Online: 22 February 2021
Competing interests
: K.H.V. is on the board of directors and shareholder of Bristol Myers Squibb, a shareholder of GRAIL, and on the science advisory board of PMV Pharma, RAZE Therapeutics, Volastra Pharmaceuticals and Ludwig Cancer. K.H.V. is a co-founder and consultant of Faeth Therapeutics, funded by Khosla Ventures. All other authors declare no competing interests.